OrthoPediatrics (NASDAQ:KIDS) Sets New 12-Month Low – What’s Next?

OrthoPediatrics Corp. (NASDAQ:KIDS)’s stock price hit a new 52-week low during mid-day trading on Monday . The stock traded as low as $21.99 and last traded at $21.99, with a volume of 210 shares trading hands. The stock had previously closed at $22.93.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on the company. Needham & Company LLC reaffirmed a “buy” rating and set a $42.00 target price on shares of OrthoPediatrics in a research report on Friday, November 8th. Truist Financial cut their price objective on OrthoPediatrics from $34.00 to $28.00 and set a “hold” rating on the stock in a report on Monday, October 14th. Finally, JMP Securities reissued a “market outperform” rating and issued a $50.00 price objective on shares of OrthoPediatrics in a report on Friday, September 13th.

OrthoPediatrics Stock Up 6.6 %

The business has a fifty day moving average price of $26.79 and a two-hundred day moving average price of $29.45. The company has a debt-to-equity ratio of 0.19, a current ratio of 7.17 and a quick ratio of 3.68. The firm has a market capitalization of $589.03 million, a price-to-earnings ratio of -19.77 and a beta of 1.16.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the company. Quarry LP acquired a new position in shares of OrthoPediatrics in the third quarter valued at about $25,000. International Assets Investment Management LLC grew its holdings in OrthoPediatrics by 2,610.8% during the third quarter. International Assets Investment Management LLC now owns 1,003 shares of the company’s stock worth $27,000 after acquiring an additional 966 shares during the period. Quest Partners LLC acquired a new stake in OrthoPediatrics during the second quarter worth about $34,000. EntryPoint Capital LLC grew its holdings in OrthoPediatrics by 56.9% during the first quarter. EntryPoint Capital LLC now owns 2,783 shares of the company’s stock worth $81,000 after acquiring an additional 1,009 shares during the period. Finally, BNP Paribas Financial Markets grew its holdings in OrthoPediatrics by 125.1% during the third quarter. BNP Paribas Financial Markets now owns 3,471 shares of the company’s stock worth $94,000 after acquiring an additional 1,929 shares during the period. 69.05% of the stock is owned by institutional investors and hedge funds.

About OrthoPediatrics

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.